DHTI · Dalrada Technology Group, Inc.
$0.02
+0.01 (+272.55%)
At close · Aug 31
Going-concern doubt
— flagged May 21, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company incurred negative cash flows from operations for the three months ended March 31, 2026, and 2025, and raises substantial doubt about our ability to continue as a going concern for the twelve-month period following the date of this report.”View the 10-Q filed May 21, 2026
Market Cap
$600,785
Shares
120.16M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$20.3M
+2.3%
FY2025
Net Income
-$24.65M
+14.9%
FY2025
Gross Margin
26.11%
+21.2pp
FY2025
Operating Margin
-100.77%
+34.5pp
FY2025
Diluted EPS
-$0.23
+25.8%
FY2025
Operating Cash Flow
-$17.97M
-128.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| $16.51M | $20.3M | $19.84M | $29.74M | $19.27M | $3.41M | $1.18M | $72.16K | $0 | |
| $12.15M | $15M | $18.86M | $20.68M | $8.76M | $2.47M | $625.92K | $75K | $0 | |
| $4.36M | $5.3M | $984.03K | $9.06M | $10.51M | $934.72K | $552.24K | -$2841 | $0 | |
| — | 26.11% | 4.96% | 30.46% | 54.53% | 27.44% | 46.87% | -3.94% | — | |
| $0 | $0 | $0 | $120K | $657K | $520.51K | $471.96K | $50.05K | $0 | |
| $19.56M | $23.02M | $27.82M | $29.47M | $20.07M | $8.98M | $2.77M | $721.85K | $91.98K | |
| $998.04K | $997.28K | $885.97K | $360.54K | $252.94K | $83.61K | $46.6K | $0 | — | |
| $22.29M | $25.76M | $27.82M | $30.02M | $20.94M | $9.5M | $3.24M | $1.04M | $91.98K | |
| -$17.93M | -$20.46M | -$26.84M | -$20.96M | -$10.44M | -$8.57M | -$2.69M | -$1.05M | — | |
| — | -100.77% | -135.26% | -70.48% | -54.16% | -251.57% | -228.25% | -1448.71% | — | |
| -$16.93M | -$19.46M | -$25.95M | -$20.6M | -$10.18M | -$8.49M | -$2.64M | -$1.05M | — | |
| -$3.76M | -$4.2M | $1.24M | $2.55M | $1.3M | $670.27K | $1.04M | $853.18K | $945.24K | |
| $176.15K | $191.86K | $85.66K | $79.76K | $4451 | $6278 | $8769 | $0 | — | |
| -$3.76M | -$4.2M | -$2.34M | $332.24K | -$1M | $8.57M | $211.54K | $1.41M | -$945.24K | |
| -$21.69M | -$24.66M | -$29.18M | -$20.63M | -$11.44M | $1221 | -$2.48M | -$774.74K | -$91.98K | |
| $28.26K | $9600 | $5600 | $0 | $132.51K | $0 | $0 | $0 | $0 | |
| -$21.75M | -$24.65M | -$28.95M | -$20.29M | -$14.1M | $91.43K | -$2.47M | $365.85K | -$1.04M | |
| — | -121.39% | -145.89% | -68.24% | -73.17% | 2.68% | -209.34% | 507.03% | — | |
| $17.22K | -$25.61K | -$237.84K | -$335.2K | $2.53M | -$90.21K | -$11.18K | $0 | — | |
| -$21.3M | -$24.52M | -$29.14M | -$20.63M | -$11.65M | $41.41K | -$2.49M | $365.85K | — | |
| USD/shares | -$0.18 | -$0.23 | -$0.31 | -$0.24 | -$0.20 | $0.00 | -$0.04 | $0.01 | -$0.02 |
| USD/shares | -$0.18 | -$0.23 | -$0.31 | -$0.24 | -$0.20 | $0.00 | -$0.04 | $0.00 | -$0.02 |
| shares | — | 108.49M | 92.24M | 83.76M | 72.22M | 70.32M | 56.8M | 47.43M | 47.28M |
| shares | — | 108.49M | 92.24M | 83.76M | 72.22M | 128.95M | 56.8M | 102.58M | 47.28M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Genefic | $10,424,584 | $13,217,899 | $15,740,919 | $13,617,639 | — |
| Dalrada Energy | $8,081,063 | $2,804,236 | — | $1,261,774 | — |
| Dalrada Technologies | $1,348,747 | $1,373,136 | $2,049,411 | $2,239,763 | $1,185,982 |
| Dalrada Precision Manufacturing | $448,409 | $2,447,148 | $4,873,225 | $2,123,437 | $481,313 |
| Corporate | $0 | $0 | $0 | $25,000 | — |
| Dalrada Climate Technology and Dalrada Energy | — | — | $7,075,414 | — | — |
| Dalrada Health | — | — | — | — | $1,739,389 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| United States | $17,410,789 | $17,194,741 | $26,208,432 | $16,536,221 | $1,889,449 |
| Spain | $1,541,380 | $310,568 | $0 | — | — |
| India | $970,053 | $1,094,468 | $1,643,476 | $2,005,949 | $1,185,981 |
| United Kingdom | $380,581 | $1,242,642 | $1,887,061 | $725,443 | $321,254 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Unrelated Parties | $18,622,330 | $18,124,587 | — | — | — |
| Service Revenue Third Parties | $11,887,749 | $4,207,133 | — | $15,584,154 | $2,020,307 |
| Healthcare Insurers Government Payers And OTC Pharmaceutical Sales | $8,431,233 | $11,745,574 | $12,546,849 | — | — |
| Product Sales Third Parties | $6,812,477 | $13,917,454 | — | $2,280,403 | $1,053,720 |
| Related Parties | $1,680,473 | $1,717,832 | — | — | — |
| Service Revenue Related Party | $1,602,577 | $1,717,692 | $2,205,438 | $1,327,732 | $270,050 |
| Product Sales Related Party | $0 | $140 | — | — | — |
| Healthcare Insurers and Government Payers | — | — | $12,546,849 | $11,824,717 | — |
| Healthcare Insurers | — | — | — | $11,824,717 | — |
| Product Sales Related Parties | — | $140 | $77,308 | $75,324 | $62,607 |
| Revenues | — | — | — | $17,864,557 | — |
| Revenues Related Party | — | — | — | $1,403,056 | — |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Dalrada Technologies | -$62,001 | -$235,104 | $10,634 | $30,177 | -$276,385 |
| Dalrada Energy | -$2,864,224 | -$6,314,398 | — | $967,639 | — |
| Genefic | -$3,617,277 | -$6,611,308 | -$5,783,441 | $2,225,304 | — |
| Dalrada Precision Manufacturing | -$4,006,023 | -$1,349,321 | -$2,461,219 | -$2,834,342 | -$2,024,154 |
| Corporate | -$9,909,185 | -$12,329,215 | -$11,660,710 | -$10,824,022 | -$4,942,487 |
| Dalrada Climate Technology and Dalrada Energy | — | — | -$1,065,221 | — | — |
| Dalrada Health | — | — | — | — | -$1,327,125 |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Genefic | -34.7% | -50% | -36.7% | 16.3% | — |
| Dalrada Energy | -35.4% | -225.2% | — | 76.7% | — |
| Dalrada Technologies | -4.6% | -17.1% | 0.5% | 1.3% | -23.3% |
| Dalrada Precision Manufacturing | -893.4% | -55.1% | -50.5% | -133.5% | -420.5% |
| Corporate | — | — | — | -43296.1% | — |
| Dalrada Climate Technology and Dalrada Energy | — | — | -15.1% | — | — |
| Dalrada Health | — | — | — | — | -76.3% |